CompanyGraph
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleMarket cap is $1.7B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.78: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.08%Below 5Y avg (1.14%)
Annual Rate
CNY 0.10Paid unknown
Payout Ratio
40.2%Sustainable
Payback Period
94.2 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
11.40BCNY1.70B · vs all stocks (USD)
Trailing P/E
37.48xRevenue (TTM)
4.97BCNY740.64M · vs all stocks (USD)
Profit Margin
6.11%Beta
0.4540xvs all stocks
52-Week Change
-33.97%vs all stocks
Forward Annual Dividend Yield
1.08%vs all stocks
Market Capitalization
11.40BCNY1.70B · vs all stocks (USD)
Enterprise Value
11.14BCNY1.66B · vs all stocks (USD)
Trailing P/E
37.48xForward P/E
15.36xPrice to Sales (TTM)
2.30xPrice to Book (MRQ)
1.10xEnterprise to Revenue
2.24xEnterprise to EBITDA
16.35xGross Margin
47.73%Profit Margin
6.11%Operating Margin
11.04%Return on Assets (TTM)
1.71%Return on Equity (TTM)
3.19%Revenue (TTM)
4.97BCNY740.64M · vs all stocks (USD)
Revenue per Share (TTM)
4.08CNYUpdated Sep 19, 2026Quarterly Revenue Growth
-7.40%Gross Profit (TTM)
2.23BCNY332.87M · vs all stocks (USD)
EBITDA (TTM)
536.20MCNY79.98M · vs all stocks (USD)
Net Income (TTM)
303.40MCNY45.25M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-34.70%Operating Cash Flow (TTM)
765.78MCNY114.22M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
38.96MCNY5.81M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1000CNYUpdated Sep 19, 2026Forward Annual Dividend Yield
1.08%vs all stocks
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 19, 2026Trailing Annual Dividend Yield
1.08%vs all stocks
5-Year Average Dividend Yield
1.14%vs all stocks
Payout Ratio
40.16%Minority Interest (Equity)
-123.55MCNYFY2025 · Dec 31, 2025Revenue
5.13BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.73BCNYFY2025 · Dec 31, 2025Gross Profit
2.41BCNYFY2025 · Dec 31, 2025Operating Income
577.24MCNY86.10M · vs all stocks (USD)
Pre-tax Income
423.70MCNYFY2025 · Dec 31, 2025Income Tax Expense
50.25MCNYFY2025 · Dec 31, 2025Net Income
373.45MCNYFY2025 · Dec 31, 2025EBIT
476.74MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
894.61MCNYFY2025 · Dec 31, 2025Research & Development
291.37MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.09BCNYFY2025 · Dec 31, 2025Other Operating Expenses
49.57MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
12.06MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
53.04MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.22BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.22BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
373.45MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
28.57MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
109.00MCNYFY2025 · Dec 31, 2025Free Cash Flow
-425.82MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
663.77MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
373.45MCNYFY2025 · Dec 31, 2025Other Non-cash Items
66.55MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-109.04MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-221.96MCNYFY2025 · Dec 31, 2025Capital Expenditures
-534.82MCNYFY2025 · Dec 31, 2025Sale of Investments
80.72MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-454.09MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.86BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.78BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-171.58MCNYFY2025 · Dec 31, 2025Other Financing Charges
-23.46MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-114.17MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.22BSharesUpdated Sep 19, 2026Float Shares
508.36MSharesUpdated Sep 19, 2026% Held by Insiders
44.01%vs all stocks
% Held by Institutions
5.69%vs all stocks
Total Cash (MRQ)
884.25MCNY131.90M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.8530CNYUpdated Sep 19, 2026Total Debt (MRQ)
2.47BCNY368.06M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2841xCurrent Ratio (MRQ)
1.29xBook Value per Share (MRQ)
8.53CNYUpdated Sep 19, 2026Total Assets
12.85BCNY1.92B · vs all stocks (USD)
Total Current Assets
3.92BCNYFY2025 · Dec 31, 2025Total Liabilities
4.13BCNYFY2025 · Dec 31, 2025Total Non-current Assets
8.92BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.10BCNYFY2025 · Dec 31, 2025Total Current Liabilities
3.03BCNYFY2025 · Dec 31, 2025Cash
663.76MCNYFY2025 · Dec 31, 2025Cash Equivalents
69.20MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
732.97MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.40BCNYFY2025 · Dec 31, 2025Inventory
1.26BCNYFY2025 · Dec 31, 2025Accounts Payable
873.39MCNYFY2025 · Dec 31, 2025Short-term Debt
1.46BCNYFY2025 · Dec 31, 2025Other Current Liabilities
8.18MCNYFY2025 · Dec 31, 2025Long-term Debt
897.83MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.73MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.04BCNYFY2025 · Dec 31, 2025Retained Earnings
4.75BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.71BCNY1.30B · vs all stocks (USD)
52-Week Low
9.07CNYUpdated Sep 19, 202652-Week High
14.73CNYUpdated Sep 19, 202652-Week Change
-33.97%vs all stocks
Beta
0.4540xvs all stocks
50-Day MA
10.04CNYUpdated Sep 19, 2026200-Day MA
11.33CNYUpdated Sep 19, 2026Avg 10-Day Volume
6.99MSharesUpdated Sep 19, 2026Avg 30-Day Volume
12.54MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
0.2500CNYUpdated Sep 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.48Profit Margin: 0.06
Financial Health
Altman Z-Score 2.78: safe zoneNotable
Altman Z-Score: 2.78
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $1.7B, above the global median of $1.18BNotable
Market cap (USD): 1,700,062,301.319Global Median: 1,180,223,658.953
Revenue is $740.64M, above the global median of $548.88MNotable
Revenue (USD): 740,640,830.054Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
Ani Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Green Thumb Industries Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Olix Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shenzhen Edge Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Shyndec Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Aosaikang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alembic Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Absci Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Hugel Inc.
Tier 1ProductionApproval-Gated PipelineRule